Pharmaceutical Regulatory Affairs: Open Access

Regulatory services and market analysis

Pharmaceutical Regulatory Services is a provider of expert clinical and regulatory support of all phases of global drug development. We support clinical and regulatory activities in the USA, European Union, as well as the emerging markets of Asia Pacific, Latin America, and Central and Eastern Europe. A market analysis studies the attractiveness and the dynamics of a special market within a special industry. It is part of the industry analysis and thus in turn of the global environmental analysis. Through all of these analyses the strengths, weaknesses, opportunities and threats (SWOT) of a company can be identified.

Related Journals of Regulatory services and market analysis

International Journal of Drug Regulatory Affairs, Clinical Research and Regulatory Affairs, International Journal of Drug Regulatory Affairs, International Journal of Pharma Research & Review (IJPRR)

High Impact List of Articles

• Phase 0 Trials and FDA and EMEA Standards′ Impact on Drug Development
  Kurt Naber*

  Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2022: 340

• Phase 0 Trials and FDA and EMEA Standards′ Impact on Drug Development
  Kurt Naber*

  Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2022: 340

• A New Way to Prevent Chemotherapy from Harming the Heart
  Harapriya Sahoo*

  Editorial: Pharmaceutical Regulatory Affairs: Open Access, 2021: .237

• A New Way to Prevent Chemotherapy from Harming the Heart
  Harapriya Sahoo*

  Editorial: Pharmaceutical Regulatory Affairs: Open Access, 2021: .237

• Physico-chemical and Preliminary Phytochemical Study of Seeds of Datisca cannabina Linn (Datiscaceae) from Himalaya Region
  Ijaz S*, Perveen A, Kousar S and Ghaffar N

  Review: Pharmaceutical Regulatory Affairs: Open Access, 2020:

• Physico-chemical and Preliminary Phytochemical Study of Seeds of Datisca cannabina Linn (Datiscaceae) from Himalaya Region
  Ijaz S*, Perveen A, Kousar S and Ghaffar N

  Review: Pharmaceutical Regulatory Affairs: Open Access, 2020:

• Schedule I Control Status Does Not Impede Legitimate Nonclinical Research
  Gauvin DV

  Review: Pharmaceutical Regulatory Affairs: Open Access, 2020:

• Schedule I Control Status Does Not Impede Legitimate Nonclinical Research
  Gauvin DV

  Review: Pharmaceutical Regulatory Affairs: Open Access, 2020:

Conference Proceedings

• Provitamin D2 - A balance between aerobic conditions and ergosterol production by Saccharomyces sp
  Anca Irina Galaction

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Provitamin D2 - A balance between aerobic conditions and ergosterol production by Saccharomyces sp
  Anca Irina Galaction

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Ceramic-polymer composites and its evaluation as a drug carrier for controlled release of Clindamycin
  Agnieszka Sobczak-Kupiec

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Ceramic-polymer composites and its evaluation as a drug carrier for controlled release of Clindamycin
  Agnieszka Sobczak-Kupiec

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Physiochemical analysis and tribological properties of composite coatings for bone regeneration
  Dagmara Slota

  Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Physiochemical analysis and tribological properties of composite coatings for bone regeneration
  Dagmara Slota

  Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• High dose vitamin C associated with acute kidney injury and mortality
  Thomas R McCune

  Keynote: Pharmaceutical Regulatory Affairs: Open Access

• High dose vitamin C associated with acute kidney injury and mortality
  Thomas R McCune

  Keynote: Pharmaceutical Regulatory Affairs: Open Access

• Activin B promotes the initiation and progression of liver fibrosis
  Guoli Dai

  Keynote: Pharmaceutical Regulatory Affairs: Open Access

• Activin B promotes the initiation and progression of liver fibrosis
  Guoli Dai

  Keynote: Pharmaceutical Regulatory Affairs: Open Access

• Pharmacokinetics of an Oral Human Growth Hormone (hGH) Formulation in Rats and Mice
  Gregory Burshtein

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

• Pharmacokinetics of an Oral Human Growth Hormone (hGH) Formulation in Rats and Mice
  Gregory Burshtein

  Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access